Edition:
United Kingdom

NU Skin Enterprises Inc (NUS.N)

NUS.N on New York Stock Exchange

82.82USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$82.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
166,887
52-wk High
$84.00
52-wk Low
$53.50

Chart for

About

Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a... (more)

Overall

Beta: 1.59
Market Cap(Mil.): $3,321.59
Shares Outstanding(Mil.): 52.94
Dividend: 0.36
Yield (%): 2.30

Financials

  NUS.N Industry Sector
P/E (TTM): 21.22 66.44 40.93
EPS (TTM): 2.96 -- --
ROI: 13.74 10.04 62.11
ROE: 21.52 14.35 73.68

BRIEF-Nu Skin Enterprises Q1 Earnings Per Share $0.64

* NU SKIN ENTERPRISES REPORTS STRONG FIRST-QUARTER RESULTS AND INCREASES ANNUAL GUIDANCE

26 Apr 2018

BRIEF-Nu Skin Enterprises Enters Into A Credit Agreement That Provides For A $400 Million Term Loan Facility

* NU SKIN ENTERPRISES SAYS ON APRIL 18, 2018 CO ENTERED INTO A CREDIT AGREEMENT THAT PROVIDES FOR A $400 MILLION TERM LOAN FACILITY - SEC FILING

23 Apr 2018

BRIEF-Nu Skin Enterprises Says Selling Stockholder To Offer Up To 1.5 Million Shares Of Co's Class A Common Stock

* NU SKIN ENTERPRISES - SELLING STOCKHOLDER TO OFFER UP TO 1.5 MILLION SHARES OF CO'S CLASS A COMMON STOCK ISSUABLE UPON CONVERSION OF CONVERTIBLE NOTES Source text: (http://bit.ly/2FHodFF) Further company coverage:

01 Mar 2018

BRIEF-Nu Skin Enterprises Announces Dividend Increase

* NU SKIN ENTERPRISES INC - HAS INCREASED QUARTERLY CASH DIVIDEND TO $0.365 FROM PREVIOUS $0.36 PER SHARE Source text for Eikon: Further company coverage:

15 Feb 2018

BRIEF-Nu Skin Enterprises Sees Fy 2018 Revenue Up 7 To 9 Percent

* NU SKIN ENTERPRISES REPORTS FOURTH-QUARTER AND 2017 RESULTS AND PROVIDES INITIAL 2018 GUIDANCE

15 Feb 2018

Earnings vs. Estimates